In addition, miR-486-5p inhibited cell proliferation and migration of CRC cell lines through direct targeting PLAGL2, thus suppressing downstream genes' expression, such as IGF2 and β-catenin. The gene discussed is PLAGL2; the disease is colorectal carcinoma.